7. Sun Pharmaceutical

Gained: 28.80 percent to 569.95 from 442.50

Market Cap: 58,976.39 Crore

Sun Pharmaceutical Industries is an international specialty pharma company. The Company manufactures and markets pharmaceutical formulations as branded generics, as well as generics in India, the United states and several other markets across the world. The Company’s business is divided into four segments: Indian Branded Generics, US Generics, International Branded Generics (ROW) and Active Pharmaceutical Ingredients (API). Its brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, diabetology and respiratory. It makes specialty APIs, including peptides, steroids, hormones and anticancers. APIs and Dosage forms are made at 20 plants across India, Israel, the United States, Canada, Hungary, Brazil, Mexico and Bangladesh. It’s API products include Acamprosate Calcium, Alendronate Sodium, Amifostine trihydrate, Budensonide and Carvedilol. In September 2010, it acquired Taro Pharmaceutical Industries Ltd.

Sun Pharmaceutical is currently traded at 577.50 and previously closed at 585.40. Its 52 week high is 603.00 and 52 week low is 422.00. It is traded with an average volume of 543,536 everyday.